Effects of electroacupuncture on the functionality of NG2-expressing cells in perilesional brain tissue of mice following ischemic stroke
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- NEURAL REGENERATION RESEARCH17(7) · pp.1556 · 2022
- 피인용
- Web of Science 14Scopus 14
- FWCI (Scopus)
- 0.91
- JCR IF
- JCR 2021 6.058
- ISSN
- 1673-5374
저자
- 이홍주제1저자Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea
- 정다희Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea
- 김남권Pusan Natl Univ, Sch Korean Med, Dept Korean Ophthalmol Otolaryngol Ana Dermatol, Yangsan, South Korea
- 신화경Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea
- 최병태교신저자Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea
초록
© 2022 Wolters Kluwer Medknow Publications. All rights reserved.Neural/glial antigen 2 (NG2)-expressing cells has multipotent stem cell activity under cerebral ischemia. Our study examined the effects of electroacupuncture (EA) therapy (2 Hz, 1 or 3 mA, 20 minutes) at the Sishencong acupoint on motor function after ischemic insult in the brain by investigating the rehabilitative potential of NG2-derived cells in a mouse model of ischemic stroke. EA stimulation alleviated motor deficits caused by ischemic stroke, and 1 mA EA stimulation was more efficacious than 3 mA EA stimulation or positive control treatment with edaravone, a free radical scavenger. The properties of NG2-expressing cells were altered with 1 mA EA stimulation, enhancing their survival in perilesional brain tissue via reduction of tumor necrosis factor alpha expression. EA stimulation robustly activated signaling pathways related to proliferation and survival of NG2-expressing cells and increased the expression of neurotrophic factors such as brain-derived neurotrophic factor, tumor growth factor beta, and neurotrophin 3. In the perilesional striatum, EA stimulation greatly increased the number of NG2-expressing cells double-positive for oligodendrocyte, endothelial cell, and microglia/macrophage markers (CC1, CD31, and CD68). EA therapy also greatly activated brain-derived neurotrophic factor/tropomyosin receptor kinase B and glycogen synthase kinase 3 beta signaling. Our results indicate that EA therapy may prevent functional loss at the perilesional site by enhancing survival and differentiation of NG2-expressing cells via the activation of brain-derived neurotrophic factor -induced signaling, subsequently ameliorating motor dysfunction. The animal experiments were approved by the Animal Ethics Committee of Pusan National University (approval Nos. PNU2019-2199 and PNU2019-2884) on April 8, 2019 and June 19, 2019.
키워드
Brain-derived neurotrophic factorDifferentiationElectroacupunctureMotor functionNeural/glial antigen 2Perilesional striatumStrokeSurvivalNG2 PROTEOGLYCANWHITE-MATTERRAT-BRAINEXPRESSIONDIFFERENTIATIONPROLIFERATIONNEUROTROPHINSACUPUNCTUREMACROPHAGESPROGENITORS
식별자
- Scopus EID
- 2-s2.0-85122013011
- WoS UID
- 000766430900033



로그인
연구물 목록으로